Oncology & Cancer

Predicting prostate cancer recurrence 15 months sooner

A Purdue University mechanical engineer and his international collaborators have developed a patent-pending method and algorithm to predict the recurrence of prostate cancer in patients treated by radiation therapy.

Oncology & Cancer

MRI scans improve prostate cancer diagnosis in screening trial

The REIMAGINE study, published today in BMJ Oncology, is the first study to use MRI scans with prostate specific antigen (PSA) density to assess the need for further standard NHS tests. Of the 29 participants found to have ...

Oncology & Cancer

Scientists get closer to a better PSA test

The most common screening test for prostate cancer so often returns a false positive result that it's no longer recommended for men older than 70, and it's offered as a personal choice for younger men.

page 3 from 32